CVE-2022-39290: falha de alta gravidade em zoneminder
CSRF key bypass using HTTP methods in zoneminder
Publicada em · Atualizada em
Aviso por e-mail quando ela entrar no KEV, ganhar PoC pública ou subir de nota.
63Vexday Risk Score
Priorize a correção. Ela exploração observada pelo VulnCheck e tem prova de conceito pública.
ssvc Actcvss 8epss 7.9%
da publicação à arma171 dias
Publicada no NVD7 de out.
1ª PoC+171d
VulnCheck+974d
ZoneMinder is a free, open source Closed-circuit television software application. In affected versions authenticated users can bypass CSRF keys by modifying the request supplied to the Zoneminder web application. These modifications include replacing HTTP POST with an HTTP GET and removing the CSRF key from the request. An attacker can take advantage of this by using an HTTP GET request to perform actions with no CSRF protection. This could allow an attacker to cause an authenticated user to perform unexpected actions on the web application. Users are advised to upgrade as soon as possible. There are no known workarounds for this issue.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H
Produtos afetados
ZoneMinder · zoneminderPoCs públicas encontradas — 2✓ VexDay Proof
exploitdb✓ VexDay Proofwww.exploit-db.com/exploits/51071cve_referencepacketstormsecurity.com/files/171498/Zoneminder-Log-Injection-XSS-Cross-Site-Request-Forgery.htmlnão verificado⚠ Recursos públicos, para você avaliar a exposição de sistemas que controla ou está autorizado a testar. Teste apenas com autorização.
CVEs relacionadas — zoneminder
No mesmo produto, das mais perigosas para as menos.
CVE-2023-26035HIGHZoneMinder vulnerable to Missing AuthorizationEPSS 80.5%CVE-2024-51482CRITICALBoolean-based SQL Injection in ZoneMinder v1.37.* <= 1.37.64EPSS 36.6%CVE-2022-39291MEDIUMDenial of service through logs in zoneminderEPSS 7.1%CVE-2024-43360CRITICALZoneMinder Time-based SQL InjectionEPSS 6.2%CVE-2022-39285HIGHStored Cross-Site Scripting Vulnerability In File Parameter in zoneminderEPSS 5.1%CVE-2023-26034CRITICALZoneMinder SQL InjectionEPSS 1.6%